Radiol Oncol 2020; 54(3): 317-328. doi: 10.2478/raon-2020-0047 317 research article Analysis of damage-associated molecular pattern molecules due to electroporation of cells in vitro Tamara Polajzer1, Tomaz Jarm1, Damijan Miklavcic1 1 Faculty of Electrical Engineering, University of Ljubljana, Ljubljana, Slovenia Radiol Oncol 2020; 54(3): 317-328. Received 18 June 2020 Accepted 7 July 2020 Correspondence to: Prof. Damijan Miklavčič, Ph.D., Faculty of Electrical Engineering, University of Ljubljana, Tržaška 25, SI-1000 Ljubljana, Slovenia. E-mail: damijan.miklavcic@fe.uni-lj.si Disclosure: No potential conflicts of interest were disclosed. Background. Tumor cells can die via immunogenic cell death pathway, in which damage-associated molecu- lar pattern molecules (DAMPs) are released from the cells. These molecules activate cells involved in the immune response. Both innate and adaptive immune response can be activated, causing a destruction of the remaining infected cells. Activation of immune response is also an important component of tumor treatment with electrochemo- therapy (ECT) and irreversible electroporation (IRE). We thus explored, if and when specific DAMPs are released as a consequence of electroporation in vitro. Materials and methods. In this in vitro study, 100 μs long electric pulses were applied to a suspension of Chinese hamster ovary cells. The release of DAMPs – specifically: adenosine triphosphate (ATP), calreticulin, nucleic acids and uric acid was investigated at different time points after exposing the cells to electric pulses of different amplitudes. The release of DAMPs was statistically correlated with cell permeabilization and cell survival, e.g. reversible and irreversible electroporation. Results. In general, the release of DAMPs increases with increasing pulse amplitude. Concentration of DAMPs de- pend on the time interval between exposure of the cells to pulses and the analysis. Concentrations of most DAMPs correlate strongly with cell death. However, we detected no uric acid in the investigated samples. Conclusions. Release of DAMPs can serve as a marker for prediction of cell death. Since the stability of certain DAMPs is time dependent, this should be considered when designing protocols for detecting DAMPs after electric pulse treatment. Key words: electroporation; pulsed electric field treatment; damage-associated molecular pattern molecules; im- munogenic cell death; electrochemotherapy Introduction Electroporation or pulsed electric field (PEF) treat- ment can cause changes in membrane perme- ability, which allows molecules, that are other- wise membrane impermeable, to cross the plasma membrane. In reversible electroporation the dam- age to cell membrane is repaired, enabling the cell to reestablish its metabolism and survive. This type of electroporation is used in multiple thera- pies. Electrochemotherapy (ECT) is one of such widely used therapies in which the increased cell membrane permeability enables chemotherapeutic drug to enter the cell and thus potentiates the cy- totoxicity of the drug.1,2 In irreversible electropora- tion (IRE) the damage to the cells however is too severe for the cells to recover which leads to cell death. While the cells are destroyed, the integrity of tissue like vessels, nerves and extracellular ma- trix remains preserved3,4, making this therapy very appealing for ablation of tumor and other tissues, otherwise unsuitable for surgical removal or ther- mal ablation such as radiofrequency ablation or cryo-ablation.5,6 Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation318 In ECT eight square 100 μs electrical pulses, with an amplitude of 100-1000 V are usually used to induce a reversible membrane permeabilization. For IRE, more pulses (80-100 pulses) at higher am- plitude (up to 3000 V) are required, to overwhelm the reparative capacity of the cells which leads to cell death.7 From morphological, biochemical, and functional perspectives, different cell death path- ways/types can be activated.8 Historically, based on morphological changes, three different forms of cell death were defined: apoptosis (cell shrinkage, chromatin condensation, formation of apoptotic bodies); autophagy (cytoplasmic vacuolization); and necrosis (loss of plasma membrane integrity).8,9 Such classification is still employed, but in newer classification based on genetic, biochemical, phar- macological and functional differences, cell death is either accidental (uncontrollable death caused by disassembly of the plasma membrane) or regu- lated (activation of signal transduction). Depending on signaling pathways different types of regulated cell death are being characterized, e.g. intrinsic and extrinsic apoptosis, necroptosis, ferroptosis, pyroptosis, immunogenic cell death, lysosome-de- pendent cell death, mitochondrial permeably tran- sition driven necrosis and many others gathered and described by Galluzi et al..10 In electroporation studies, cell death has been most extensively ex- plored in the range of nanosecond pulse treatment, where the majority of studies confirmed cell death by apoptosis (intrinsic and extrinsic) and only few studies indicated necrosis.11,12 Both pathways were confirmed also in microsecond pulse treatment.13-9 Nevertheless, in recent studies new cell death types were also detected like pyroptosis20, necroptosis20,21 and immunogenic cell death.22-29 In IRE 18,30-34 and ECT with either bleomycin or cisplatin26,35-37 used for cancer treatment, involve- ment and importance of host immune response was demonstrated, counteracting tumor escape mechanisms.29,38,39 After these therapies, dying tu- mor cells can release specific molecules, which are being recognized by the cells of immune system. These molecules can activate the innate and adap- tive immune response, leading to the destruction of the remaining tumor cells in the body40 and induc- ing long-lasting protective antitumor immunity.41 Some studies even suggest that immunogenic effect of IRE is more pronounced than in other ablation therapies like radiofrequency ablation31 and cryoa- blation.32 Evidence suggests that administration of immune-stimulating molecules can even enhance the local effectiveness of ECT35 and IRE29,42-44 allow- ing simultaneous treatment of distant tumors. Our immune system consists of two comple- mentary and closely collaborative systems, an innate (non-specific) and an adaptive (antigen- specific) system. Activation of immune system is essential for our survival, as it distinguishes and eliminates potentially harmful molecules, even the ones that derive from the host/our own tissues. Well known are the pathogen-associated molecules (PAMPs), which are present on microbes and are being recognized by cells of the innate immune system when they bind to pattern recognition re- ceptors (PRRs). The same pathways are activated by the host’s damage-associated molecular pat- tern molecules (DAMPs), which act as endogenous damage signal in case of cell death or response to stress, leading to inflammatory response.45-47 Release of DAMPs characterizes immunogenic cell death (ICD). Most of DAMPs are normally lo- cated intracellularly48, where under normal physi- ological conditions have an important intracellular role. When a cell is damaged or dies, DAMPs are actively or passively exposed or released to extra- cellular space.49-51 The release of DAMPs is often accompanied by cytokines, chemokines and other inflammatory mediators.52 In extracellular space DAMPs have a completely different function, as they are being recognized by pattern recognition receptors (PRRs), such as TRLs, NOD-like, PRLs and RAGE receptors on immune cells.50,53 Binding of DAMPs to these receptors stimulates innate im- mune response through promoting the release of pro-inflammatory mediators and recruiting im- mune cells (dendritic cells, macrophages, T cells and neutrophils). Usually, the exposure of differ- ent DAMPs depends on endoplasmic reticulum stress, followed by reactive oxygen species (ROS) production.41 Release of DAMPs correlates with the degree of trauma.54 Some DAMPs can even be involved in tissue repair pathway.55-57 It depends on DAMPs and their triggered pathways, together with cytokines and growth factor to determine, if mild acute inflammation and wound healing 56,58 or severe inflammation and fibrosis will follow.59 Electroporation causes an increase in membrane permeability and allows molecules, for which the membrane is usually impermeable, including DAMPs, to cross it. ATP, one of the main DAMPs, was even used as an indicator of cell membrane permeabilization in the first electroporation stud- ies.60 In recent years reports on electroporation studies have started to emerge investigating the immunogenic cell death caused by electroporation. Studies detected DAMPs, like ATP, high-mobility group box 1 protein (HMGB1) release and calreti- Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation 319 culin externalization, as they are the gold standard for predicting the ICD in cancer cells.41 So far most- ly single (or a small subset of) DAMPs were stud- ied. Most studies involved nanosecond pulse treat- ment22-25, whereas studies using microsecond26,29, millisecond28 and H-FIRE pulse treatments27 are even more scarce. For now, different DAMPs were investigated at different intervals after electropora- tion ranging from 30 min to 72 hours, using differ- ent types of cancer cells. Because in both ECT and IRE the immune sys- tem response is essential for successful and com- plete tumor eradication, we decided to explore if and when specific DAMPs are released in response to electroporation in vitro. The experiments were performed using 100 μs long pulses, as they are most commonly used in ECT treatment and in IRE for soft tissue ablation. Materials and methods Cell preparation Chinese hamster ovary (CHO-K1) from European Collection of Authenticated Cell Cultures were grown in culture flasks (TPP, Switzerland) filled with HAM F-12 growth medium (PAA, Austria) at 37°C with a humidified 5% CO2. The growth me- dium was enriched with 10% fetal bovine serum (FBS) (Sigma-Aldrich, Germany), L-glutamine (StemCell, Canada) and antibiotics penicillin/ streptomycin (PAA, Austria) and gentamycin (Sigma-Aldrich, Germany). At 70% confluency, cells were detached with trypsin solution (10x trypsin-EDTA (PAA, Austria) 1:9 diluted in Hank’s basal salt solution (StemCell, Canada), which was inactivated after 3 minutes by the growth medium. After 5 minutes of centrifugation at 180 g and 22°C supernatant was removed. Cell were mixed with the growth medium to obtain cell density at 2x106 cells/ml. Electric pulse generation Laboratory prototype pulse generator (University of Ljubljana), based on H-bridge digital amplifier with 1 kV MOSFETs (DE275-102N06A, IXYS, USA), described in 61 was used. Eight 100 μs long mo- nopolar electric pulses with repetition frequency 1 Hz and amplitude of 0–600 V (0-3 kV/cm; voltage to distance ratio) with increments of 100 V (and additional increments in the permeabilization as- say) were applied between stainless steel 304 plate electrodes (d = 2 mm). Oscilloscope HDO6104A- MS, differential probe HVD3206A and the current probe CP031A, all from LeCroy, USA, were used to monitor the delivered pulses, i.e. voltage and current. The delivered voltage was approximately 10-15% lower than the value set on the pulse gen- erator and the current was in the range of 3-21 A. When pulses with high amplitudes were applied (Figure 1), current decreased slightly during the pulse, presumingly due to electrochemistry at elec- trode-electrolyte interface reducing the available interface area for ion exchange between the metal electrode and the electrolyte and possibly also due to ion depletion at the said interface. Results First, the permeabilization and the survival curves were obtained to determine experimental points for the studies on release of DAMPs. Permeabilization and survival curves are presented in all figures showing the concentration of various DAMPs to visualize how the presence of DAMPs is related to changes in permeabilization and cell viability. In figures the permeabilization and survival curves are shown only at pulse amplitudes tested for the presence of DAMPs; in steps of 50 V in the range of pulses where changes in permeabilization occur and in steps of 100 V above 200 V. The concentration of ATP in supernatant was first measured with fluorescent method 30 minutes and FIGURE 1. Application of 500 V pulses. Blue line shows voltage and red line shows current. Due to sequencing, all eight pulses are in one picture, separated by //. Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation320 24 hours after electroporation (Figure 2). At 30 min- utes the concentration of ATP in supernatant was detected at 200 V. However, statistical difference between the control and the treatment groups (ob- tained by one-way analysis of variance [ANOVA] followed by the post-hoc test) was only detected at 500 V and above. The concentration of ATP in su- pernatant grew with increasing pulse amplitude, which after 24 hours led to decreased cell viability; e.g. correlation between the cell survival and ATP concentration in supernatant detected after 30 min is quite strong and negative; R = -0.864. Also, weak correlation between cell permeabilization and ATP concentration in supernatant (R = 0.594) confirms, that ATP presence in supernatant is more strongly correlated with the irreversible than the reversible electroporation. It may indicate that strong ATP re- lease from cells leads to cell death. After 24 hours (Figure 2) the lowest ATP con- centration was achieved at the pulse amplitude resulting in death of most cells (500, 600 V). The concentration of ATP at these points is statistically different to the results obtained 30 minutes after pulse treatment. After 24 hours the concentration of ATP had decreased with the lower viability, but statistical differences between the control and the treatment groups were present from 400 to 600 V. At 24 hours there is a positive statistical correlation between the cell survival and concentration of ATP in supernatant (R = 0.888), which is stronger than the correlation to permeabilization (R = -0.695). Since no ATP was detected in supernatant with- in the range of reversible electroporation after 30 minutes using the fluorescent method (Figure 2), we also used a more sensitive luminescent method (Figure 3). Furthermore, since ATP analysis showed that 24 h after treatment ATP is not detected in all samples, we were also interested in how fast ATP was degraded. Scuderi et at. showed complete re- sealing of plasma membrane 10 minutes after pulse treatment using 8 x 100 μs pulses.63 Thus, another time point for ATP measurement was chosen, i.e. 15 minutes after (Figure 3). With more sensitive luminescent detection assay, ATP was detected in supernatant already at 100 V, however statistically significant difference to control was only detected at 300 V and higher. These results are more reliable due to higher assay sensitivity however even with this method statistically significant amount of ATP in supernatant is detected in the range of irrevers- ible electroporation, as increased electric field/volt- age kills more cells more ATP is present in the ex- tracellular space. This is also confirmed by a strong correlation between the survival and the amount of ATP in supernatant, R = -0.947 for 15 min and R = -0.964 for 30 min, and much weaker correlation between the permeabilization and the amount of ATP (R = 0.704 for 15 min and R = 0.728 for 30 min). In our results, only one significant difference was found in detected ATP amount between 15 and 30 minutes after pulse treatment at 500 V. Since this FIGURE 2. Release of adenosine triphosphate (ATP) as a function of electric pulse amplitude determined by fluorescent assay. Two-time points after electroporation were assessed. Permeabilization and survival curves are also presented. Black and green asterisks (*) indicate statistically significant differences between the samples at different voltages and the corresponding control at 0 V (one-way analysis of variance [ANOVA] followed by Holm-Sidak post-hoc test, (p < 0.05) and within the pair of samples at different voltages (t-test, p < 0.05), respectively). FIGURE 3. Release of adenosine triphosphate (ATP), as a function of electric pulse amplitude determined by luminescence assay. Two-time points after electroporation were assessed. Permeabilization and survival curves are also presented. Black and green asterisks (*) indicate statistically significant differences between the samples at different voltages and the corresponding control at 0 V (one-way analysis of variance [ANOVA] followed by Holm-Sidak post-hoc test, (p < 0.05) and within the pair of samples at different voltages (t-test, p < 0.05), respectively). Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation 321 difference was not detected for all the experimental points (voltages), we believe that ATP in extracel- lular space is not degraded in this first 30 minutes after pulse treatment. Calreticulin (CRT) is an endoplasmic reticulum protein which needs to be transferred to the outer leaflet of the plasma membrane in order to act as a DAMP. Externalization of calreticulin to outer membrane in an active process involving also its transport across the cell. Due to this active and time demanding process the externalization of calreticulin was investigated 4 and 24 hours (also used in previous studies23-25,28) after pulse treat- ment (Figure 4) on viable cells (determined by pro- pidium iodide [PI] staining). Calreticulin was first detected at 300 V and its fluorescence increased with increasing voltage of pulses. Furthermore, the lowest viability at 600 V with < 5% of viable cell has the strongest signal of calreticulin after 4 and 24 hours. This could indicate the amount of externalized calreticulin per viable cell increases with the level of stress (amplitude of applied elec- tric pulses). Furthermore, analysis shows a strong correlation between survival determined by MTS test and externalization of calreticulin, as survival decreased, the detection of calreticulin increased (R = -0.801 for 4h and R = -0.946 for 24h) and weak correlation between permeabilization and exter- nalization of calreticulin was observed (R = 0.535 for 4h and R = 0.556 for 24h). Since calreticulin was detected only in viable cells (determined by PI) ad- ditional information on viability was obtained, and results were normalized to control (0 V) for each investigated time point separately. Except for the results at 300 V, no statistically significant differ- ence between 4 and 24 hours was detected at any other experimental point, suggesting that calreti- culin can be detected 4 hours after pulse treatment and that expression of the protein remains stable for the next 20 hours. Until now, nucleic acids (in the role of DAMPs) have not been investigated in relation to electropo- ration. Most of RNA (except fresh transcripted mRNA) is located in cytoplasm, while DNA is lo- cated in the cell nucleus. The concentration of RNA and DNA in supernatant has been detected 15, 30 minutes and 24 hours after electroporation like in ATP assay (Figure 5 and 6). Concentration of DNA/ RNA started to rise from 400 V up (Figure 5 and 6). This happened at the same pulse amplitudes where after 24 hours cell viability was affected, indicating the amount of nucleic acid occurs in the range of cell death, i.e. irreversible electroporation. Exposure of cells to higher pulse amplitudes caused higher release of nucleic acids, which after 24 h resulted in lower cell viability. This is confirmed also by a strong negative correlation between survival and FIGURE 4. Externalization of calreticulin as a function of electric pulse amplitude. Two-time points after electroporation were assessed. Permeabilization and survival (MTS) curves are also presented. Survival detected by propidium iodide (PI) protocol is normalized to control and presented with red (4 hours after pulse treatment) and orange (24 hours after pulse treatment) line. Approximate baseline of calreticulin is presented with -----. Black and green asterisks (*) indicate statistically significant differences between the samples at different voltages and the corresponding control at 0 V (one-way analysis of variance [ANOVA] followed by Holm-Sidak post- hoc test, (p < 0.05) and within the pair of samples at different voltages (t-test, p < 0.05), respectively). FIGURE 5. Release of RNA as a function of electric pulse amplitude. Three-time points after electroporation were assessed. Permeabilization and survival curves are also presented. Approximate baseline of RNA is presented with -----. Black and green asterisks (*) indicate statistically significant differences between the samples at different voltages and the corresponding control at 0 V (one-way analysis of variance [ANOVA] followed by Holm-Sidak post-hoc test, (p < 0.05) and within the pair of samples at different voltages (t-test, p < 0.05), respectively). Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation322 release of RNA (R = -0.909 for 15 min, R = -0.909 for 30 min, R = -0.919 for 24 h) and weak correlation between permeabilization and release of RNA (R = 0.584 for 15 min, R = 0.696 for 30 min, R is not sig- nificant for 24 h), respectively. Similarly, for DNA, a strong correlation between survival and release of DNA (R = -0.935 for 15 min, R = -0.919 for 30 min, R = -0.928 for 24 h) and a weak correlation between permeabilization and release of DNA (R = 0.571 for 15 min, R = 0.689 for 30 min, R is not significant for 24 h) was found. This correlation may indicate that loss of nucleic acids results in cell death. Comparison of the concentration of RNA de- tected in supernatant 15, 30 minutes and 24 hours after pulse treatment did not show any significant differences. Comparison of the concentration of DNA detected in supernatant 15, 30 minutes and 24 hours after pulse treatment showed only signifi- cant differences between 15 and 30 minutes at 600 V, yet interestingly this was not the case between 15/30 minutes and 24 hours after pulse treatment. According to our results, the released nucleic acids in vitro are stable and are not degraded within 24 hours after pulse treatment. We also tried to detect uric acid, another well know DAMP molecule. The release of uric acid in supernatant was analyzed 24 hours after pulse treatment (Figure 7). In our experiments we were however unable to detect any uric acid in superna- tant after pulse treatment. Initial experiments were also performed after 30 minutes, but results were the same (data not shown). Discussion Besides the induced membrane permeabilization, followed by cell death, activation of the immune response seems to be an important component in effectiveness of ECT26,35-37 and IRE18,30-34 treatment in vivo. Activation of the immune system can be trig- gered by a special type of cell death, called immu- nogenic cell death (ICD) in which DAMPs are the key mediators.64 Presence of DAMPs after pulse treatment has been detected in different types of cancer cells and normal tissues.22-29 However, only one study was performed with 100 us pulses, which are predominantly used in ECT and IRE.26 The au- thors investigated release of ATP, calreticulin and HMGB1 due to electroporation pulses alone, bleo- mycin alone and combination of electroporation pulses and bleomycin. Their study demonstrated the release of ATP and calreticulin after pulse treat- ment, but how this correlates to reversible and/or irreversible electroporation remained elusive. This question is addressed in our study, were release/ detection of different DAMPs was correlated with permeabilization and survival curve in vitro. Detected amounts of DAMPs were correlated to cell membrane permeabilization determined by PI assay immediately after pulse treatment and cell survival, analyzed 24 hours after treatment by FIGURE 6. Release of DNA as a function of electric pulse amplitude. Three-time points after electroporation were assessed. Permeabilization and survival curves are also presented. Approximate baseline of DNA is presented with -----. Black and green asterisks (*) indicate statistically significant differences between the samples at different voltages and the corresponding control at 0 V (one-way analysis of variance [ANOVA] followed by Holm-Sidak post-hoc test, (p < 0.05) and within the pair of samples at different voltages (t-test, p < 0.05) respectively. FIGURE 7. Release of uric acid as a function of electric pulse amplitude. Amount of uric acid was analysed 24 hours after pulse treatment in supernatant. Permeabilization and survival curves are also presented. No statistical difference was detected. Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation 323 MTS test, i.e. to reversible and irreversible elec- troporation, respectively. It is generally believed that membrane permeabilization and cell survival after pulse treatment are causally related, i.e. in IRE cell death occurs due to membrane permeabiliza- tion and loss of cell homeostasis (in this study cor- relation coefficient between the two is -0.680) and in ECT increased accumulation of drug leads to in- creased cell cytotoxicity. In ECT and IRE it was also demonstrated that the immune response plays an important role in achieving therapeutic effect.33-36 We have therefore determined different DAMPs at different times after exposing the cells to electric pulses and de- termined whether the concentrations of extracel- lular DAMPs were better correlated to cell death or to membrane permeabilization. While activation inflammatory response and activation of immune system is desired in cancer therapies, on the other hand it can be a wanted or an unwanted effect in gene therapy.68,69 In DNA vaccination therapies, changed permeability of cell membrane enhances the introduction of DNA vaccine inside of cell and the presence of DAMPs additionally activates in- flammatory response, which leads to enhanced production of antibodies, thus enhancing the ef- ficiency of vaccination.65-67 Nevertheless, in most cases of gene therapy, the immune response in un- wanted, as it may destroy the transfected cells and prevent transgenic protein expression.68,69 By now many DAMPs have been identified and the number is still increasing. Most known are the HMGB1, nu- cleic acids, proteins like heat-shock proteins, S100 and calreticulin, purine metabolites like ATP and uric acid and saccharides. A list of know DAMPs and their receptors is given by Roh and Sohn.48 ATP is a well-known molecule in biology and biochemistry for being a universal energy source in the cell and necessary for multiple cell processes and cell metabolism. Interestingly, first studies of electroporation and increase in plasma membrane permeability involved adenosine triphosphate ATP detection in electroporation buffer.70 The released ATP is also considered a DAMP. In our study two types of ATP detection methods with different sen- sitivities were used.71,72 In a previous study per- formed by Calvet et al.26 using the same pulses as in our study, the release of ATP was detected 30 min- utes after the treatment. We were able to confirm their observations with the fluorescence and the luminescence method (Figures 2 and 3 respective- ly). Furthermore, the investigation of the effects at different pulse amplitudes showed that the release of ATP increases with increasing amplitude. This was expected, as ATP release was previously used as a permeability marker after electroporation.70 However, in our results statistical differences be- tween the control and the treatment groups were not detected in the range where the permeabiliza- tion curve is ascending, but was detected only in the range of pulse amplitudes at which all cells were already permeabilized and many were dead. Since ANOVA analysis is less sensitive when large amount of samples with big differences between them are analyzed, additional ANOVA was per- formed, taking into account only the results from 0 to 300 V (e.g. where permeabilization changes from 0 to 100%). Now additional analysis showed that statistical differences between control and the treatment groups are present at 200 V and above in luminescent method, suggesting ATP release as possible membrane permeabilization detection method. In the fluorescence method, this statisti- cal difference was obtained only at 300 V. Such dif- ference in analysis and also a bigger ratio of ATP between the control and the treatment groups indi- cates that the luminescence method is more sensi- tive method than the fluorescence method. Taken into consideration ATP release at all investigated voltages (also the one leading to cell death after 24 hours) the release of ATP is more strongly corre- lated to cell death/irreversible electroporation (R = 0.888) than permeability/reversible electroporation (R = -0.695). 24 hours after pulse treatment (Figure 2) the highest amount of ATP was detected in the super- natant of control sample and the amount of ATP decreased with increasing pulse amplitude. This can be explained by homeostasis of ATP in living cells. In a living homeostatic cell most of the ATP is located intracellularly, however in considerably lower concentration ATP is also present in extracel- lular space.73 When cells are damaged, considerable release of ATP molecule affects ATP pumps, caus- ing depletion of intracellular K+ and accumulation of intracellular NA+ and Ca2+ and leading to cell death.74 A previous study showed that electropo- ration pulses cause ATP depletion, which in 24 re- sults in lower viability, presumingly by affecting Ca2+-ATPase.75 In our study the effect on survival was also confirmed by very strong positive corre- lation between survival/irreversible electropora- tion and amount of ATP detected in supernatant (R = 0.888). Nevertheless, we need to consider, that some of the ATP detected in supernatant could be from the cells damaged due to cell handling during experiment. In extracellular space ATP is degraded by nucleotides like CD39 and CD37, which convert Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation324 ATP through ADP and AMP to adenosine73, which explains why ATP was detected 30 minutes at very high voltages (500, 600 V), but was no longer de- tected after 24 hours (Figure 2). This can also ex- plain why Calvet et al.26, was unable to detect ATP 30 hours after pulse treatment alone, however it does not explain, why ATP was still detected when bleomycin alone or in combination with electropo- ration pulses was used. How fast ATP degrades in extracellular space, remains unknown. Our results do not indicate that ATP degrades within the first 30 minutes after pulse treatment, since no differ- ence between 15 and 30 minutes after pulse treat- ment was detected. In a different study76 the results for ATP 4 hours after pulse treatment was lower in samples exposed to pulse treatment than in the control. If this is taken into consideration together with our results, then ATP degradation in vitro oc- curs somewhere between 30 minutes and 4 hours after pulse treatment. Calreticulin was another molecule of interest in our study. This highly conserved protein has major functions in lumen of the endoplasmic reticulum (ER). It is involved in correct folding of proteins that are produced in endoplasmic reticulum77 and in regulation of calcium metabolism, as it affects Ca2+ capacity of the ER stores.78 In the early phase of cell death, activated ER stress leads to transloca- tion of calreticulin to cells surface trough ER-Golgi pathway or lysosome exocytosis.79,80 Calreticulin, as DAMP, was investigated previously in electropo- ration studies.22-26,28 In Calvets’s study26, which used the same pulses as in our study (eight 100 μs pulses), calreticulin was determined 30 hours after treatment using different treatments. Calreticulin was detected on the plasma membrane after elec- troporation pulses alone or in combination with bleomycin (ECT), yet no externalization was de- tected in cells threated with bleomycin alone. Since only calreticulin, exposed on the cell surface acts as a DAMP, only viable cells (determined by PI) were taken into analysis. The presence of calreti- culin on the cell surface was previously detected already 4 hours after electroporation with milli- second pulses28, thus we assumed 4 hours is suf- ficient time for calreticulin to transfer to cells sur- face. Additionally, calreticulin was detected also 24 after pulse treatment. In our study calreticulin was investigated 4 and 24 hours after treatment (Figure 4), which is after the resealing of cell mem- brane.63 Even though calreticulin was detected on the surface of live cells, it was detected only in the range of irreversible electroporation. Additionally, calreticulin detection increased with decreasing cell viability (less viable cells), implicating that big- ger stress or in this case pulse amplitude causes more calreticulin molecules to be externalized to cell surface. Nevertheless, since it is believed that externalization of calreticulin occurs in early phase of cell death79,80, it is possible that cell determined as viable would die within next hours. In comparison to ATP, calreticulin is more sta- ble. Only at 300 V the difference between 4 and 24 hours was statistically significant. Stability of externalized calreticulin was previously also con- firmed in another in vitro study.24 Nevertheless, in vivo study shows expression is the strongest be- tween four and six hours, and diminishes 24 h after the treatment.28 So far studies investigating DAMPs, released by the electroporation treatment, included ATP, calreticulin and HMGB1. In addition to ATP and calreticulin we also included other known DAMPs in our study, namely nucleic acids and uric acid, which so far have not been investigated as DAMPs after electroporation. Inside the cells nucleic acids are the source of genetic information. As DAMPs in extracellular space nucleic acids bind to TLR receptors. Bound DNA can even attract HMGB1 (a non-histone nuclear protein, which can be ac- tively or passively released into extracellular space, where it acts as a DAMP81) and together they form complexes stimulating dendritic cells to produce type 1 interferon (non-specific immune response), which can lead to anti-DNA autoan- tibody production (specific immune response).82 Nucleic acids (RNA and DNA) can be detected in supernatant already within minutes after pulse treatment (Figure 5,6). Nevertheless, we need to consider – based on the control, 0 V in Figures 5 and 6, that some of the nucleic acids detected in supernatant could be from the cells damaged due to cell handling during experiment. Since RNA is more abundantly present in cells than DNA83,84, the same was expected to be the case in the super- natant after pulse treatment. However, the amount of detected DNA in our samples was bigger than that of RNA. Since RNA is more prone to degra- dation than DNA84, it is possible that some of the RNA was destroyed during the process of analy- sis. Nevertheless, the amount of released nucleic acids increases with increasing voltage of electric pulses to which the cells were exposed. Our results indicate that the release of nucleic acids (RNA and DNA) occurs in the range of irreversible electropo- ration; i.e. pulse amplitudes that lead to cell death as determined by MTS test at 24 h post treatment. This was confirmed also by very strong negative Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation 325 correlation between the cell survival and the re- lease for RNA and DNA. Uric acid is a product of purine metabolism within the cell, like degradation of nucleic acids, and is released from injured and dying cells.85 A molecule that is soluble inside the cell, accumu- lates in extracellular space, where it is transformed in insoluble crystal of monosodium urate, stimu- lating the maturation of dendritic cells and T-cell response.85,86 Here, the presence of uric acid after electroporation was investigated for the first time. Presence of uric acid in supernatant was inves- tigated 24 hours after electroporation treatment (Figure 7). We expected uric acid to show a simi- lar behavior in pulse parameter dependency as other DAMPs. However, we did not detect uric acid in supernatant after pulse treatment. Standard curve was obtained, therefore Uric Acid Assay Kit worked. Maybe uric acid production did not hap- pen or uric acid was still inside of cells and not yet in supernatant as predicted. Furthermore, we found no existing data on CHO cells and uric acid in the literature, so maybe formation of uric acid in ovarian cells does not occur. With respect to the results obtained, detection of DAMPs and its correlation to cell membrane per- meabilization and cell survival seems to be more complex than initially thought. Even a DAMP like ATP, which can be released due to electropo- ration alone is better correlated to cell survival than membrane permeabilization (Tables 1, 2). A recent study performed by Ringel-Scaia et al.27, in which multiple signaling pathways were ana- lyzed, showed that the cell and cell population is a dynamic system which changes with time. Two hours after pulse treatment RNA analyses showed activation of immunosuppressive pathway, cell in- jury and apoptosis. With time these genes became less pronounces and after 24 hours change in gene expression indicated proinflammatory response, cell repair and necrosis/pyroptosis. This explains changes in DAMPs detection hours after pulse treatment, including the presence and absence of different DAMPs and its correlation with cell sur- vival. Since statistical correlations between DAMP release and cell survival is much stronger than with membrane permeabilization, involvement of immune system in IRE can be explained. However, activation of immune system was demonstrated also in ECT treatments, were reversible electropo- ration is used. How can that be, if correlation be- tween membrane permeabilization and released DAMPs is weak or does not even exist? Modeling87 and in vivo experiments88 show that application of TABLE 1. Correlation (R) between survival and release of damage-associated molecular pattern molecules (DAMPs) after pulse treatment. Investigated time points for each molecule are presented in the bottom row. Correlation was evaluated with Pearson correlation coefficient and survival was analyzed via MTS assay 24 hours after pulse treatment R vs. survival (MTS) PI -0.680 ATP -0.947 (L) -0.964 (L)/-0.864 (F) 0.888 (F) DNA -0.935 -0.919 -0.928 RNA -0.909 -0.909 -0.919 CRT -0.801 -0.946 uric acid NS time points after EP 3 min 15 min 30 min 4 h 24 h ATP = adenosine triphosphate; CRT = calreticulin; (F) = fluorescence assay; (L) = luminescence assay; NS = no statistical significance; PI = propidium iodide TABLE 2. Correlation (R) between permeabilization and release of damage- associated molecular pattern molecules (DAMPs) after pulse treatment. Investigated time points for each molecule are present in the bottom row. Correlation was evaluated with Pearson correlation coefficient and permeabilization was analyzed by propidium iodide (PI) assay 3 minutes after pulse treatment R vs permeabilization (PI) MTS -0.680 ATP 0.704 0.728 (L)/0.594 (F) -0.695 (F) DNA 0.571 0.689 NS RNA 0.584 0.696 NS CRT 0.535 0.556 uric acid NS time points after EP 3 min 15 min 30 min 4 h 24 h ATP = adenosine triphosphate; CRT = calreticulin; (F) = fluorescence assay; (L) = luminescence assay; NS = no statistical significance nominally reversible electroporation pulses such as those used for ECT of tumors still causes some cell death by means of irreversible electroporation in tissue close to the electrodes, due to inhomoge- neous electric field distribution, which can thus lead to the release of DAMPs and activation of the immune system. The aim of this study was to explore, if and when specific DAMPs are released as a conse- quence of electroporation and if the release of DAMPs can be correlated to reversible and/or ir- reversible electroporation. Even though detection of certain DAMPs remains uncertain, others show strong correlation to cell survival/irreversible elec- Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation326 troporation and much weaker correlation to mem- brane permeabilization/reversible electroporation. Release of DAMPs could perhaps serve as a pre- dictor of cell death. In addition, it may indicates that the stability of certain DAMPs is questionable and thus their presence and detectability is time dependent. This needs to be taken into considera- tion when designing protocols to detect DAMPs after electroporation treatment. Finally, to obtain a better insight of DAMP release with respect to electroporation treatment other cell types includ- ing also cancer cell types should be investigated. Acknowledgements Authors would like to thank L. Vukanović and D. Hodžić for their help in the cell culture laboratory and Dr. Matej Reberšek for help with pulse record- ing and image production. The research was sup- ported by Medtronic and the Slovenian Research Agency (research core funding No. IP-0510, P2-0249 and grant to young researcher Tamara Polajžer). References 1. Orlowski S, Belehradek J, Paoletti C, Mir LM. Transient electropermea- bilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. J Biochem Pharmacol Res 1988; 3: 4727-33. doi: 10.1016/0006- 2952(88)90344-9 2. Mir LM. Bases and rationale of the electrochemotherapy. EJC Suppl 2006; 4: 38-44. doi: 0.1016/j.ejcsup.2006.08.005 3. Scheffer HJ, Nielsen K, De Jong MC, Van Tilborg AJM, Vieveen JM, Bouwman A, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol 2014; 25: 997-1011. doi: 10.1016/j.jvir.2014.01.028 4. Phillips M, Maor E, Rubinsky B. Nonthermal irreversible electropora- tion for tissue decellularization. J Biomech Eng 2010; 132: 091003. doi: 10.1115/1.4001882 5. Davalos RV, Mir LM, Rubinsky B. Tissue ablation with irreversible electropo- ration. Ann Biomed Eng 2005; 3: 223-31. doi: 10.1007/s10439-005-8981-8 6. Chen X, Ren Z, Zhu T, Zhang X, Peng Z, Xie H, et al. Electric ablation with irreversible electroporation (IRE) in vital hepatic structures and follow-up investigation. Sci Rep 2015; 5: 16233. doi: 10.1038/srep16233 7. Jiang C, Davalos RV, Bischof JC. A review of basic to clinical studies of irre- versible electroporation therapy. IEEE Trans Biomed Eng 2015; 62: 4-20. doi: 10.1109/TBME.2014.2367543 8. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007; 14: 1237-43. doi: 10.1038/sj.cdd.4402148 9. Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Exp Teratol 1973; 7: 253-66. doi: 10.1002/tera.1420070306 10. Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the nomencla- ture committee on cell death 2018. Cell Death Differ 2018; 25: 486-541. doi: 10.1038/s41418-017-0012-4 11. Batista Napotnik T, Rebersek M, Vernier PT, Mali B, Miklavcic D. Effects of high voltage nanosecond electric pulses on eukaryotic cells (in vitro): a systematic review. Bioelectrochemistry 2016; 110: 1-12. doi: 10.1016/j. bioelechem.2016.02.011 12. Beebe SJ. Regulated and apoptotic cell death after nanosecond electropo- ration. In: Miklavčič D, editor. Handbook of electroporation. Heidelberg: Springer International Publishing; 2017. p. 511-28. doi: 10.1007/978-3-319- 32886-7_146 13. Chai W, Zhang W, Wei Z, Xu Y, Shi J, Luo X, et al. Irreversible electroporation of the uterine cervix in a rabbit model. Biomed Microdevices 2017; 19: 103. doi: 10.1007/s10544-017-0248-2 14. Kim HB, Sung CK, Baik KY, Moon KW, Kim HS, Yi JH, et al. Changes of apop- tosis in tumor tissues with time after irreversible electroporation. Biochem Biophys Res Commun 2013; 435: 651-6. doi: 10.1016/j.bbrc.2013.05.039 15. Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electropo- ration: Ultrasound and immunohistological correlation. Technol Cancer Res Treat 2007; 6: 287-93. doi: 10.1177/153303460700600404 16. Lee EW, Wong D, Tafti BA, Prieto V, Totonchy M, Hilton J, et al. Irreversible electroporation in eradication of rabbit VX2 liver tumor. J Vasc Interv Radiol 2012; 23: 833-40. doi: 10.1016/j.jvir.2012.02.017 17. Zhang Z, Li W, Procissi D, Tyler P, Omary RA, Larson AC. Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following ir- reversible electroporation ablation. Nanomedicine 2014; 9: 1181-92. doi: 10.2217/nnm.13.72 18. José A, Sobrevals L, Ivorra A, Fillat C. Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. Cancer Lett 2012; 317: 16-23. doi: 10.1016/j.canlet.2011.11.004 19. Al-Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV, et al. Tumor ablation with irreversible electroporation. PLoS One 2007; 2: e1135. doi: 10.1371/journal.pone.0001135 20. Zhang Y, Lyu C, Liu Y, Lv Y, Chang TT, Rubinsky B. Molecular and histological study on the effects of non-thermal irreversible electroporation on the liver. Biochem Biophys Res Commun 2018; 500: 665-70. doi: 10.1016/j. bbrc.2018.04.132 21. López-Alonso B, Hernáez A, Sarnago H, Naval A, Güemes A, Junquera C, et al. Histopathological and ultrastructural changes after electroporation in pig liver using parallel-plate electrodes and high-performance generator. Sci Rep 2019; 9: 2467. doi: 10.1038/s41598-019-39433-6 22. Nuccitelli R, Berridge JC, Mallon Z, Kreis M, Athos B, Nuccitelli P. Nanoelectroablation of murine tumors triggers a cd8-dependent inhibition of secondary tumor growth. PLoS One 2015; 10: e0134364. doi: 10.1371/ journal.pone.0134364 23. Nuccitelli R, McDaniel A, Anand S, Cha J, Mallon Z, Berridge J, et al. Nano- pulse stimulation is a physical modality that can trigger immunogenic tumor cell death. J Immunother Cancer 2017; 5: 32. doi: 10.1186/s40425-017- 0234-5 24. Guo S, Jing Y, Burcus NI, Lassiter BP, Tanaz R, Heller R, et al. Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases. Int J Cancer 2018; 142: 629-40. doi: 10.1002/ijc.31071 25. Rossi A, Pakhomova ON, Mollica PA, Casciola M, Mangalanathan U, Pakhomov AG, et al. Nanosecond pulsed electric fields induce endoplasmic reticulum stress accompanied by immunogenic cell death in murine models of lymphoma and colorectal cancer. Cancers 2019; 11: 2034. doi: 10.3390/ cancers11122034 26. Calvet CY, Famin D, André FM, Mir LM. Electrochemotherapy with bleomy- cin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology 2014; 3: e28131. doi: 10.4161/onci.28131 27. Ringel-Scaia VM, Beitel-White N. Lorenzo MF, Brock RM, Huie KE, Coutermarsh-Ott S. High-frequency irreversible electroporation is an ef- fective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity. EBioMedicine 2019; 44: 112-25. doi: 10.1016/j.ebiom.2019.05.036 28. Schultheis K, Smith, TRF, Kiosses WB, Kraynyak KA, Wong A, Oh J, et al. Delineating the cellular mechanisms associated with skin electroporation. Hum Gene Ther Methods 2018; 29: 177-88. doi: 10.1089/hgtb.2017.105 29. Zhao J, Wen X, Tian L, Li T, Xu C, Wen X, et al. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer. Nat Commun 2019; 10: 1-14. doi: 10.1038/s41467-019-08782-1 Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation 327 30. Vogl TJ, Wissniowski TT, Naguib NNN, Hammerstingl RM, Mack MG, Münch S, et al. Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases. Cancer Immunol Immunother 2019; 58: 1557-63. doi: 10.1007/s00262-009-0663-1 31. Bulvik BE, Rozenblum N, Gourevich S, Ahmed M, Andriyanov AV, Galun E, et al. Irreversible electroporation versus radiofrequency ablation: a compari- son of local and systemic effects in a small-animal model. Radiology 2016; 280: 413-24. doi: 10.1148/radiol.2015151166 32. White SB, Zhang Z, Chen J, Gogineni VR, Larson AC. Early immunologic re- sponse of irreversible electroporation versus cryoablation in a rodent model of pancreatic cancer. J Vasc Interv Radiol 2018; 29: 1764-9. doi: 10.1016/j. jvir.2018.07.009 33. Scheffer HJ, Stam AGM, Geboers B, Vroomen LGPH, Ruarus A, de Bruijn B, et al. Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation. Oncoimmunology 2019; 8: 1652532. doi: 10.1080/2162402X.2019.1652532 34. Pandit H, Hong YK, Li Y, Rostas J, Pulliam Z, Li P, et al. Evaluating the regula- tory immunomodulation effect of irreversible electroporation (ire) in pan- creatic adenocarcinoma. Ann Surg Oncol 2019; 26: 800-6. doi: 10.1245/ s10434-018-07144-3 35. Calvet CY, Mir LM. The promising alliance of anti-cancer electrochemo- therapy with immunotherapy. Cancer Metastasis Rev 2016; 35: 165-77. doi: 10.1007/s10555-016-9615-3 36. Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immuno- gene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315-27. doi: 10.1007/s00262-015-1724-2 37. Serša G, Miklavcic D, Cemazar M, Belehradek J, Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti- tumor effectiveness in immunocompetent and immunodeficient mice. Bioelectrochem Bioenerg 1997; 43: 279-83. doi: 10.1016/S0302- 4598(96)05194-X 38. Gerlini G, Tun-Kyi A, Dudli C, Burg G, Pimpinelli N, Nestle FO. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 2004; 165: 1853-63. doi: 10.1016/ S0002-9440(10)63238-5 39. Gerlini G, Di Gennaro P, Mariotti G, Urso C, Chiarugi A, Pimpinelli N, et al. Indoleamine 2,3-dioxygenase cells correspond to the BDCA2 plasmacytoid dendritic cells in human melanoma sentinel nodes. J Investig Dermatol 2010; 130: 898-901. doi: 10.1038/jid.2009.307 40. Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, et al. High-voltage electrical pulses in oncology: irreversible elec- troporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy. Radiology 2020; 295: 192190. doi: 10.1148/ra- diol.2020192190 41. Zhou J, Wang G, Chen Y, Wang H, Hua Y, Cai Z. Immunogenic cell death in cancer therapy: Present and emerging inducers. J Cell Mol Med 2019; 23: 4854-65. doi: 10.1111/jcmm.14356 42. Alnaggar M, Lin M, Mesmar A, Liang S, Qaid A, Xu K, et al. Allogenic natural killer cell immunotherapy combined with irreversible electroporation for stage iv hepatocellular carcinoma: survival outcome. Cell Physiol Biochem 2018; 48: 1882-93. doi: 10.1159/000492509 43. Yang Y, Qin Z, Du D, Wu Y, Qiu S, Mu F, et al. Safety and short-term efficacy of irreversible electroporation and allogenic natural killer cell immunotherapy combination in the treatment of patients with unresectable primary liver cancer. Cardiovasc Intervent Radiol 2019; 42: 48-59. doi: 10.1007/s00270- 018-2069-y 44. Lin M, Liang S, Wang X, Liang Y, Zhang M, Chen J. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (Stage III/IV) pancreatic cancer: a promis- ing treatment. J Cancer Res Clin Oncol 2017; 143: 2607-18. doi: 10.1007/ s00432-017-2513-4 45. Diercks GFH, Kluin PM. Basic principles of the immune system and autoim- munity. In: Jonkman FM, editor. Autoimmune bullous diseases. Heidelberg: Springer International Publishing; 2016. p. 3-12. doi: 10.1007/978-3-319- 23754-1_1 46. Kellie S, Al-Mansour Z. Overview of the immune system. In: Skwarczynski M, Toth I, editors. Micro- and nanotechnology in vaccine development. Elsevier Inc; 2017. p. 63-81. doi: 10.1016/B978-0-323-39981-4.00004-X 47. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol 2010; 125: S3. doi: 10.1016/j.jaci.2009.12.980 48. Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw 2018; 18: e27. doi: 10.4110/in.2018.18.e27 49. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13: 54-61. doi: 10.1038/nm1523 50. Kato J, Svensson CI. Role of extracellular damage-associated molecular pattern molecules (DAMPs) as mediators of persistent pain. Prog Mol Biol Transl Sci 2015; 131: 251-79. doi: 10.1016/bs.pmbts.2014.11.014 51. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about dan- ger. J Leukoc Biol 2007; 81:1-5. doi: 10.1189/jlb.0306164 52. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M. Science in medicine Alarmins : awaiting a clinical response. J Clin Invest 2012; 122: 2711-9. doi: 10.1172/JCI62423.tification 53. Rock KL, Lai JJ, Kono H. Innate and adaptive immune responses to cell death. Immunol Rev 2011; 243: 191-205. doi: 10.1111/j.1600-065X.2011.01040.x 54. Stoecklein VM, Osuka A, Lederer JA. Trauma equals danger - damage con- trol by the immune system. J Leukoc Biol 2012; 92: 539-51. doi: 10.1189/ jlb.0212072 55. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18: 1028-40. doi: 10.1038/nm.2807 56. Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L, Maurelli R. High- mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 2008; 128: 1545-53. doi: 10.1038/ sj.jid.5701212 57. Yang S, Xu L, Yang T, Wang F. High-mobility group box-1 and its role in angio- genesis. J Leukoc Biol 2014; 95: 563-74. doi: 10.1189/jlb.0713412 58. Zampell JC, Yan A, Avraham T, Andrade V, Malliaris S, Aschen S, et al. Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema. Am J Physiol Cell Physiol 2011; 300: 1107-21. doi: 10.1152/ajpcell.00378.2010 59. Duffield JS, Lupher M, Thannickal VJ, Wynn TA. Host responses in tissue repair and fibrosis. Annu Rev Pathol 2013; 8: 241-76. doi: 10.1146/annurev- pathol-020712-163930 60. Rols MP, Teissié J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys J 1990; 58: 1089-98. doi: 10.1016/ S0006-3495(90)82451-6 61. Sweeney DC, Reberšek M, Dermol J, Rems L, Miklavčič D, Davalos RV. Quantification of cell membrane permeability induced by monopolar and high-frequency bipolar bursts of electrical pulses. Biochim Biophys Acta Biomembr 2016; 1858: 2689-98. doi: 10.1016/j.bbamem.2016.06.024 62. Batista Napotnik T, Miklavčič D. In vitro electroporation detection methods – an overview. Bioelectrochemistry 2018; 120: 166-82. doi: 10.1016/j.bioel- echem.2017.12.005 63. Scuderi M, Rebersek M, Miklavcic D, Dermol-Cerne J. The use of high- frequency short bipolar pulses in cisplatin electrochemotherapy in vitro. Radiol Oncol 2019; 53: 194-205. doi: 10.2478/raon-2019-0025 64. O’Brien MA, Power DG. Clover AJP, Bird B, Soden DM, Forde PF. Local tumour ablative therapies: opportunities for maximising immune en- gagement and activation. Biochim Biophys Acta 2014; 184: 510-23. doi: 10.1016/j.bbcan.2014.09.005 65. Babiuk S, Baca-Estrada ME, Foldvari M, Middleton DM, Rabussay D, Widera G, et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004; 110: 1-10. doi: 10.1016/j.jbiotec.2004.01.015 66. Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P. Enhancement of cellular immune response to a prostate cancer DNA vaccine by in- tradermal electroporation. Mol Ther 2006; 13: 320-7. doi: 10.1016/j. ymthe.2005.08.005 67. Chiarella P, Massi E, De Robertis M, Sibilio A, Parrella P, Fazio VM, et al. Electroporation of skeletal muscle induces danger signal release and antigen- presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 2008; 8: 1645-57. doi: 10.1517/14712598.8.11.1645 Radiol Oncol 2020; 54(3): 317-328. Polajzer T et al. / Damage-associated molecular pattern molecules release from cells after electroporation328 68. Bessis N, Garcia Cozar FJ, Boissier MC. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther 2004; 11(Suppl 1): S10-7.. doi: 10.1038/sj.gt.3302364 69. Shirley JL, de Jong YP, Terhorst C, Herzog RW. Immune responses to viral gene therapy vectors. Mol Ther 2020; 28: 709-22. doi: 10.1016/j. ymthe.2020.01.001 70. Rols MP, Teissié J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys J 1990; 58: 1089-98. doi: 10.1016/ S0006-3495(90)82451-6 71. Fan F, Wood KV. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 2007; 5: 127-36. doi: 10.1089/adt.2006.053 72. Wood KV. The bioluminescence advantage. [cited 2020 May 12]. Available at: https://worldwide.promega.com/resources/pubhub/enotes/the-biolu- minescence-advantage/ 73. Falzoni S, Donvito G, Di Virgilio F. Detecting adenosine triphosphate in the pericellular space. Interface Focus 2013; 3: 2012. doi: 10.1089/adt.2006.053 74. Wang XQ, Xiao AY, Sheline C, Hyrc K, Yang A, Goldberg MP, et al. Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Sci 2003; 116: 2099-110. doi: 10.1242/jcs.00420 75. Hansen EL, Sozer EB, Romeo S, Frandsen SK, Vernier PT, Gehl J. Dose- dependent ATP depletion and cancer cell death following calcium electropo- ration, relative effect of calcium concentration and electriamount strength. PLoS One 2015; 10: e0122973. doi: 10.1371/journal.pone.0122973 76. Ashdown CP, Johns SC, Aminov E, Unanian M, Connacher W, Friend J, et al. Pulsed low-frequency magnetic fields induce tumor membrane disrup- tion and altered cell viability. Biophys J 2020; 118: 1552-63. doi: 10.1016/j. bpj.2020.02.013 77. Krause KH, Michalak M. Calreticulin. Cell 1997; 88: 439-43. doi: 10.1016/ s0092-8674(00)81884-x 78. Gelebart P, Opas M, Michalak M. Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum. Int J Biochem Cell Biol 2005; 37: 260-6. doi: 10.1016/j.biocel.2004.02.030 79. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immuno- genic cell death. Embo J 2009; 28: 578-90. doi: 10.1038/emboj.2009.1 80. Kranz P, Neumann F, Wolf A, Classen F, Pompsch M, Ocklenburg T, et al. PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). Cell Death Dis 2017; 8: e2986. doi: 10.1038/cddis.2017.369 81. Hou W, Zhang Q, Yan Z, Chen R, Zeh HJ, Kang R, et al. Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death Dis 2013; 4: e966. doi: 10.1038/cddis.2013.493 82. Pisetsky DS. The origin and properties of extracellular DNA: from PAMP to DAMP. Clin Immunolog 2012; 144: 32-40. doi: 10.1016/j.clim.2012.04.006 83. Shinohara K, Toné S, Ejima T, Ohigashi T, Ito A. Quantitative distribution of DNA, RNA, histone and proteins other than histone in mammalian cells, nuclei and a chromosome at high resolution observed by scanning transmission soft x-ray microscopy (stxm). Cells 2019; 8: 164. doi: 10.3390/ cells8020164 84. Mackenzie RJ. DNA vs. RNA – 5 key differences and comparison. Technology Networks. [cited 2020 Jun 9]. Available at: https://www.technologynet- works.com/genomics/lists/what-are-the-key-differences-between-dna- and-rna-296719. 85. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-21. doi: 10.1038/nature01991 86. Shi Y, Galusha SA, Rock KL. Cutting Edge: elimination of an endogenous adjuvant reduces the activation of cd8 t lymphocytes to transplanted cells and in an autoimmune diabetes model. J Immunol 2006; 176: 3905-8. doi: 10.4049/jimmunol.176.7.3905 87. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and fo: DNA electrotransfer for gene therapy. Biochim Biophys Acta Gen Subj 2000; 1523: 73-83. doi: 10.1016/S0304-4165(00)00101-X 88. Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs. Sci Rep 2019; 9: 3649. doi: 10.1038/s41598-019-40395-y